chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Encephalitis; Seizure; Chronic autoimmune issues; This case was reported by a consumer via interactive digital media and described the occurrence of encephalitis in a male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced encephalitis (serious criteria GSK medically significant), seizure (serious criteria GSK medically significant) and autoimmune disorder (serious criteria GSK medically significant). On an unknown date, the outcome of the encephalitis, seizure and autoimmune disorder were unknown.   It was unknown if the reporter considered the encephalitis, seizure and autoimmune disorder to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Bexsero in 2002. It was reported that this was one of the four vaccinations that the patient received for work in 2002 (it was not FDA approved until 2005, so the patients were used as test subjects) and the patient experienced encephalitis and seizures. The patient also experienced chronic autoimmune issues. The patient visited the emergency room for the events. The patient had not experienced the events within 15 minutes of receiving Bexsero, that the reporter could not record it as such and ended up in the data used for adverse reaction reports during the testing phase.
Starting in the early hours of 01/01/2021, I had a massive asthma attack that woke me from my sleep. I needed to use my inhaler. I was sick with congestion for almost 2 months. Initially it was very severe and involved the sinus and chest. I ended up developing secondary sinus infections and a cough (that lasted 2 months), and possibly could have had GI symptoms (but can't remember). I was treated with 2 different courses of antibiotics for the secondary sinus infections. Also, I was tested for COVID but it was negative. Since having COVID, I feel like this could have been that. The entire time I was sick, I was also VERY fatigued and experienced shortness of breath that still lingers today.
4 funerals of people who have died 3 to four days after getting the COVID-19 vaccine; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program COVAX Support. This consumer reported similar events for four patients. This is one of four reports.  A patient of unspecified age and gender received BNT162B2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that he has been doing some research on the amount of people who have died from taking the COVID-19 vaccine and what adverse events they have had after receiving the vaccine. He stated that he has personally gone to 4 funerals of people who have died 3 to four days after getting the COVID-19 vaccine but stated he didn't know whether they were Moderna or Pfizer or (Company name withheld) and he doesn't know one person who has died from the actual virus. He just wanted information. The patient died on an unspecified date.  It was not reported if an autopsy was performed.   The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101252919 same reporter/drug/AE, different patient;US-PFIZER INC-202101252918 same reporter/drug/AE, different patient;US-PFIZER INC-202101252916 same reporter/drug/AE, different patient;US-PFIZER INC-202101252917 same reporter/drug/AE, different patient; Reported Cause(s) of Death: 4 funerals of people who have died 3 to four days after getting the COVID-19 vaccine
Throat tightening, coughing, difficulty taking deep breath. Evaluated by EMS-Cleared
Patient presented to the clinic with a rash consistent with shingles. This rash occurred 3 weeks post 2nd dose COVID vaccination. Pt treated with valtrex. Today is the first day of treatment. Pt was also treated with a course of steroids today for additional rash thought to be related to contact dermatitis. Patient had exposure to poison sumac.
2 hr p/vax pt became fussy, refusing food, felt warm;given APAP by mom cont fussy;began loud cry, diff to soothe;11JAN95 mom called clinic for advice was referred to PMD;MD saw pt 11JAN95 4PM dx ear infect;t106, sz activity; no breathing
Feel like passing out; Itching/Itching on and off; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Jun-2021 and was forwarded to Moderna on 16-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching/Itching on and off) and PRESYNCOPE (Feel like passing out) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, the patient experienced PRURITUS (Itching/Itching on and off). On an unknown date, the patient experienced PRESYNCOPE (Feel like passing out). At the time of the report, PRURITUS (Itching/Itching on and off) and PRESYNCOPE (Feel like passing out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Transverse Myelitis; A spontaneous report  was received from a consumer, concerning an 86-year-old, male patient and experienced transverse myelitis/myelitis transverse.  The patient's medical history was not reported. No relevant concomitant medications were reported.  On 05 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On 05 Feb 2021, the patient experienced transverse myelitis and was hospitalized on 23 Feb 2021.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event of transverse myelitis was unknown.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Patient recieved the Menactra vaccine. Within approx. 3 minutes she had mini seizure and had an episode of syncope that lasted approx. 1 minute. Patient stiffened up and slid out of a chair from a sitting position and was lowered to the floor. Dizziness and vertigo lasted for about 20 minutes after and then started to ease.
Headache, Fatigue, Sinus pain, Runny nose, Sore throat.
I ran a low grade fever of 100.3 for 2 days; had a severe headache; joint pain; nausea; diarrhea; body aches; runny nose; dry cough; This is a spontaneous report from a contactable other hcp (patient herself).   A 45-years-old female patient received bnt162b2 (BNT162B2, formulation: solution for injection , lot number: 301308A, expiration date: not reported), via an unspecified route of administration, administered in Arm Left on 15Sep2021 19:30 (at the age of 45 years) as dose 1, single for COVID-19 immunization. Medical history included Known allergies from Flu vaccine, Eggs, Coconut, Seafood and Lyrica. Patient had no COVID prior vaccination. Concomitant medication(s) included ibuprofen (IBUPROFEN) taken for an unspecified indication, start and stop date were not reported; paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. On 16Sep2021 at 06:00, the patient ran a low grade fever of 100.3 for 2 days, had a severe headache, joint pain, nausea, diarrhea, body aches, runny nose, dry cough. Patient had Covid test type post vaccination: Nasal swab on 27Sep2021 and results were Negative. Patient did not receive any treatment. Clinical outcome of the event was reported as recovered in Sep-2021.  Follow-Up (14Oct2021): Follow-up attempts are completed. No further information is expected.
Td given 5/30/06. No reaction to Hep A (#!) c/o red, blister in appearance rash on 6/1/06 (2 days later) or R elbow L armpit, L upper arm area, both sides of neck and spots on "torso". Pt questioned poss poison ivy exposure as walked doge in park known for poison ivy and has sensitivity to it. Had not called MD (traveling to China next day). Advised to call MD (after hours, Friday :M).
Approximately 2 months after 2nd vaccination, severe muscle pain in upper back legs, under buttocks; muscle pain in upper arms; pain in right knee.  Muscle pain so severe that it made dressing difficult.  Difficulty getting up/down; difficulty getting into car, i.e., at worse point, had to lift my legs into the car.  I consulted primary care doctor.  We stopped statin drug.   Referred to see orthopedic doctor for legs.  Saw doctor at orthopedics; exam and x-rays.  Prescribed steriods and suggested PT.  Steriods took pain away almost immediately.  Once off steriods, pain returned.  Primary care doctor ordered extra lab work.  Since May 26, 2021, primary care doctor has been prescribing steriods just to keep me out of pain.  Awaiting appointment with rheumatologist.
3x2 inch red patch at injection site that became black and blue, Itching all over her body.
Information has been received from a physician concerning a 4 year old female patient who on 19-JUN-2009 was vaccinated with a 0.5ml dose of MMR II (lot # 663667/0036Y) subcutaneously. There were no drug reactions, allergies, other medical history and concomitant medication. On 20-JUN-2009, one day after receiving vaccine, the patient developed redness and warmth at the injection site of the left upper arm. The patient was seen in a local unspecified emergency room on 20-JUN-2009 and was prescribed unspecified antibiotics to treat cellulitis. The patient was seen in follow-up in the office on 22-JUN-2009 and again on 25-JUN-2009. No lab diagnostics study was performed. At the time of report, the cellulitis was resolving. The lot number of sterile diluent was 4127X. The physician was concerned that the cellulitis might be related to the sterile diluent and requested a lot check. A standard lot check investigation was performed. All in-process quality checks for the lot number (4127X for sterile diluent) in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluations and Research and was released. This one of several reports received from the same source. Additional information has been requested.
-  Vertigo for over 2+ months since vaccinated; - Increased shortness of breath over 2+ months sine vaccinated;  - Increased heart rate, as high as 133 bpm, and maintaining over 100  for over 2+ months since vaccinated; - Dehydration for over 2+ months since vaccinated; - Increased respiratory rate, 18-20 breaths per minute, for over 2+ months since vaccinated - Extreme fatigue/malaise for over 2+ months since vaccinated; - Dizziness for over 2+ months since vaccinated; - Loss of appetite for over 2+ months since vaccinated; - Depression for over 2+ months since vaccinated;
Patient / was administrated with Pediarix instead of Kinrix; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 4-year-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number K7TF9, expiry date 24th May 2021) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th April 2021, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 28th April 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that the patient  was administrated with Pediarix instead of Kinrix, which led to wrong vaccine administered. No adverse event was reported. The reporter Consented to follow up.
Starting 04/03/2022, I developed a mild sore throat. Then, the next day, I got half a dozen canker sores in my mouth and tested myself for COVID which I was positive on 04/04/2022. Then I got swelling in my lips. I got different "hot spots" inside and on the side of my lips that were localized sites of swelling. I tested negative on 04/13/2022. My lips are still swollen and I am currently treating my mouth with a corticosteroid mouth wash (dexamethasone) in hopes to reduce the swelling.
pt recvd vaxd 4AUG95; day of shot irritability began immed ran temp 103 x 3 days;vomiting began next day & lasted 3 days; fussiness began 3 days;
Information has been received from a health professional concerning a 12 month old female pt with no known allergies and no past vaccination who on 05/16/2001 was vaccinated with MMR II. Concomitant vaccine therapy included varicella virus vaccine live and poliovirus vaccine (IPOL). There as no other concomitant medication. On 05/24/2001 the pt's mother called the office because of a mild rash and a fever in the child. On 05/25/2001, the pt was seen in the office. Her temperature at the time of the visit was 99.3 and the rash was described as an extensive urticaria type rash on face and trunk. The pt's mother reported that the rash began around the umbilicus and spread across the torso then the extremities as scattered maculopapular erythematous areas which became confluent. On her legs, the urticaria was described more as angioedema. None of the rash blistered, it did not resemble measles and it was not chicken pox. It was noted that over the 6-8 hrs before the appointment, the rash continued to extend and bruising developed in some areas. Her temperature was 102.1 and she was irritable. The physician recommended cool compresses and ibuprofen and the pt was sent to the ER. A urine culture by catheterization came back negative for any infection and the CBC showed a slightly elevated white count of 11.9 with a normal hemoglobin and platelet count. The chest x-ray was suggestive of bronchial wall thickening, but there was no pulmonary complaints or involvement. On 05/26/2001 the pt was seen again in the physician's office. Her temperature was 100 and her mother remained concerned about the swelling of the lower extremities. It was noted that the pt had a probable angioedema of the lower extremities as well as some bruising around the buttocks and back. The physician prescribed Atarax about 5mg every 6 hrs. On 05/27/01 she had another follow-up appointment. The pt's mother was concerned about a temperature of 103 on the previous night. At the office visit it was 101. It was reported that the rash on the legs had started to improve but new lesions formed on the scalp and around the nose and mouth. Some bruising was still evident. A quick strep test was done and was negative. The pt's dose of Atarax was increased to 7.5mg QID. As of 05/29/2001, the pt's temperature had settled back to baseline and her urticaria also responded nicely. Skin bruising was still noted. The pt was instructed to continue the Atarax as prescribed for the following 48 hours. It was noted that the pt had "almost completely recovered." Follow-up info received from a physician reported that the rash had completely resolved. Additional info has been requested.
Mild fever, body ache, malaise, possible palpitations; lasting 1 day.
My son received the Varicella vaccine on June 15 2006. On the morning of June 17, he woke up and had numerous spots all over him. As the day went on, he kept getting more spots and then they turned into blisters in the evening. He now has a full blown case of chicken pox. He has them on his face, arms, legs, bottom, in his ears, and on his chest.
Around January 15th, 2022, I began to have symptoms of what seemed like a bladder infection, but was far more serious. The urine was a brown color. When I woke up, I have strong pain on my low back, on my right side. My urine became dark brown and bloody. I went to urgent care on January 16th due to the pain, and it was identified as a right kidney infection. I was given strong antibiotics and pain medicine, I was also given a shot in my arm to just manage the pain, which caused me to faint for 30 seconds. The medications administered were ciprofloxacin, and hydrocodone acetamin, the shot I was given was ketolarac. Over the course of a few days, the infection got better. There is no longer bloody urine that is a brown color, just a slight lingering sore feeling.
Sent to the emergency room for persistent cough on 12/13/21. Workup in the ER revealed a sodium of 123, normal white count, but a significantly decreased platelet count of 81. Patient was given infusion of  Regeneron and was supposed to be discharged home, but given the fact that the patient is 90 years old and still having some shortness of breath, patient was admitted on 12/13/21. The patient, due to high risk, probably needs to be put in the hospital at least for a few days to see how she responds, and depending upon her chest x-ray results and for her low sodium.  She does complain of a cough productive occasionally of yellowish-green sputum. No epistaxis or hemoptysis. No chest pain. No nausea, vomiting, diarrhea. No abdominal pain. Placed on doxycycline and dexamethasone for 7 days. Did require 2 L of NC eventually. Discharged on 12/15/21.
Extreme neck pain, increase blood sugar & confusion. Fever & chills began two days later. Took to doctor's office on 01/25/2010 & was referred to ER where she was diagnosed with UTI & sent home with oral antibiotics. Health continued to deteriorate so had her taken by ambulance to ER where she wad admitted due to deminished mental capacity. Diagnosed with Viral Encaphlitis. A lumbar puncture done on 02/03/2010 to confirm diagnoses. IV anitibiotic was administered for 21 days. On 02/08/2010 was transferred to nursing home for completement of IV. Never regained health.
Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Follow-up document received includes no new information was added.
This spontaneous report was received from a consumer (also reported as husband) regarding a female patient of an unknown age. Information on patient's relevant medical history, concurrent conditions and concomitant medications were not reported. On 16-APR-2018, the patient was vaccinated with PNEUMOVAX 23 (strength, dose, frequency, route of administration, lot# and expiry date were not reported) for vaccine booster. On 16-APR-2018, the patient felt tired in a weird way, drained at "2:24pm EST" (fatigue) and pain at the injection site. On 17-APR-2018 at 5 pm, (also reported as today), the patient's arm developed a splotchy rash not where the shot was. The patient's husband reports that it was around the front of the arm and about 6 inches down. The patient reported that the arm felt sore like someone had hit her with a baseball bat (pain in extremity). The patient reported that it was stiff (musculoskeletal stiffness). The husband reported that the doctor was contacted and the doctor recommended that the patient should put ice where it was swollen and the rash was located. The doctor said that the patient could take TYLENOL if it gets worse. The patient reported that she was nauseated from eating. Laboratory data was not reported. The outcome of the events, the patient's arm developed a splotchy rash not where the shot was, feeling stiff and feeling nauseated from eating was not recovered/not resolved. The outcome of the events, felt tired in a weird way, drained at "2:24pm EST, the arm felt sore like someone hit her with a baseball bat, swollen, pain at the injection site was unknown. Causality assessment was not reported.
Initial report received from a healthcare professional on 25 march 2013. A 37-year old female patient had received first intramuscular dose of ADACEL vaccine (Lot number U4586AA, anatomical site of vaccinations was not reported on 25 March 2013. The patient was pregnant at the time of vaccination. The last menstrual period date was 16 July 2012 and the expected date of delivery was 22 April 2013. The patient's health during pregnancy and risk factors (e.g.: alcohol, tobacco or recreational drugs) were not reported. As per reporter, the patient did not experience any adverse event. List of documents held by the sender: None.
I was approximately 6.5 weeks pregnant when I was administered the flu vaccine.  My baby stopped growing and never got bigger than 6.5 weeks along.  I was diagnosed with a miscarriage a few weeks later. The heartbeat stopped and embryo never grew past that point.
12/29/2020 8:00pm developed fever, chills  and tachycardia. Employee reported feeling better in morning 12/30/2020, reported to work and completed
Pt had varivax on 2/4/99. On 6/5/01, pt has herpes zoster (shingles) in right axilla, >15 spots on dermatome. Just dx'd. Expect recovery.
Pt received Varivax and Prevnar on 11/9/05. Mom noticed bumps a week later after staying at aunts. Aunt had a dog with fleas so attributed spot to flea bite. She noticed a scab (pt was itching) with bumps around it (not sure if fluid filled). Took her to ER and was told had infection related to vaccine site and started on Keflex to pt tid times 10 days. Mom brought her to office to be rechecked. Yellow scab with erythema and surrounding dry pustules on right upper thigh.
dizziness, headache, weakness, fatigue. Three days later, I am still dizzy and have a headache.